Thrombophilia associated with anti-DFS70 autoantibodies

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Marlet, Julien ^a   Ankri, Annick ^a   Charuel, Jean Luc ^a   Ghillani Dalbin, Pascale ^a   Perret, Amélie ^a   Martin Toutain, Isabelle ^a   Haroche, Julien ^a,b   Amoura, Zahir ^a,b   Musset, Lucile ^a   Miyara, Makoto ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Assistance publique Hôpitaux de Paris   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BLOOD CLOTTING FACTOR 5 LEIDEN; DFS70 AUTOANTIBODY; UNCLASSIFIED DRUG; PSIP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; AGED; ALOPECIA AREATA; ARTERY DISEASE; ARTERY THROMBOSIS; ARTICLE; ATOPIC DERMATITIS; BLOOD DONOR; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ECLAMPSIA; FEMALE; FETUS DEATH; GENE; HOMOZYGOSITY; HUMAN; IDIOPATHIC ARTERIAL DISEASE; IDIOPATHIC DISEASE; IMMUNOPATHOGENESIS; INTERSTITIAL CYSTITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MTHFR GENE; MULTIPLE SCLEROSIS; MYOSITIS; PARTIAL THROMBOPLASTIN TIME; PREMATURITY; PREVALENCE; PROTHROMBIN GENE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOPHILIA; THYROIDITIS; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; VERY ELDERLY; VOGT KOYANAGI SYNDROME; BLOOD; CONNECTIVE TISSUE DISEASES; IMMUNOLOGY; INDIRECT FLUORESCENT ANTIBODY TECHNIQUE; MIDDLE AGED; PATHOLOGY; THROMBOSIS; YOUNG ADULT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; COHORT STUDIES; CONNECTIVE TISSUE DISEASES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; THROMBOPHILIA; THROMBOSIS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84946944054     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138671     Document Type: Article

References (39)

1. Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Annals of the rheumatic diseases. 2014; 73(1):17-23. Epub 2013/10/16. doi: 10.1136/annrheumdis-2013-203863 PMID: 24126457.
2. Solomon DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis and rheumatism. 2002; 47(4):434-44. Epub 2002/09/05. doi: 10.1002/art.10561 PMID: 12209492.
3. Agmon-Levin N, Shapira Y, Selmi C, Barzilai O, Ram M, Szyper-Kravitz M, et al. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. Journal of autoimmunity. 2010; 34(1):55-8. Epub 2009/11/10. doi: 10.1016/j.jaut.2009.08.009 PMID: 19897339.
4. Ochs RL, Stein TW Jr., Peebles CL, Gittes RF, Tan EM. Autoantibodies in interstitial cystitis. The Journal of urology. 1994; 151(3):587-92. Epub 1994/03/01. PMID: 8308964.
5. Daugaard M, Baude A, Fugger K, Povlsen LK, Beck H, Sorensen CS, et al. LEDGF (p75) promotes DNA-end resection and homologous recombination. Nature structural & molecular biology. 2012; 19 (8):803-10. Epub 2012/07/10. doi: 10.1038/nsmb.2314 PMID: 22773103.
6. Miyara M, Albesa R, Charuel JL, El Amri M, Fritzler MJ, Ghillani-Dalbin P, et al. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort. Clinical & developmental immunology. 2013; 2013:703759. Epub 2013/03/12. doi: 10.1155/2013/703759 PMID: 23476678; PubMed Central PMCID: PMCPmc3580898.
7. Ochs RL, Muro Y, Si Y, Ge H, Chan EK, Tan EM. Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. The Journal of allergy and clinical immunology. 2000; 105 (6 Pt 1):1211-20. Epub 2000/06/16. PMID: 10856157.
8. Okamoto M, Ogawa Y, Watanabe A, Sugiura K, Shimomura Y, Aoki N, et al. Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. Journal of autoimmunity. 2004; 23(3):257-66. Epub 2004/10/27. doi: 10.1016/j.jaut.2004.07.004 PMID: 15501396.
9. Shinohara T, Singh DP, Chylack LT Jr. Review: Age-related cataract: immunity and lens epitheliumderived growth factor (LEDGF). Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics. 2000; 16(2):181-91. Epub 2000/05/10. PMID: 10803429.
10. Yamada K, Senju S, Shinohara T, Nakatsura T, Murata Y, Ishihara M, et al. Humoral immune response directed against LEDGF in patients with VKH. Immunology letters. 2001; 78(3):161-8. Epub 2001/10/02. PMID: 11578690.
11. Watanabe A, Kodera M, Sugiura K, Usuda T, Tan EM, Takasaki Y, et al. Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis and rheumatism. 2004; 50(3):892-900. Epub 2004/03/17. doi: 10.1002/art.20096 PMID: 15022332.
12. Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis and rheumatism. 2011; 63(1):191-200. Epub 2010/10/19. doi: 10.1002/art.30084 PMID: 20954189.
13. National Clinical Guideline C. National Institute for Health and Clinical Excellence: Guidance. Venous Thromboembolic Diseases: The Management of Venous Thromboembolic Diseases and the Role of Thrombophilia Testing. London: Royal College of Physicians (UK)National Clinical Guideline Centre.; 2012.
14. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis and rheumatism. 1997; 40(9):1601-11. Epub 1997/10/27. PMID: 9324014.
15. Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF. The mutation Ala677 - > Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thrombosis and haemostasis. 1997; 77(5):818-21. Epub 1997/05/01. PMID: 9184384.
16. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al. Mutations in coagulation factors in women with unexplained late fetal loss. The New England journal of medicine. 2000; 343(14):1015-8. Epub 2000/10/06. doi: 10.1056/nejm200010053431405 PMID: 11018168.
17. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996; 88(10):3698-703. Epub 1996/11/15. PMID: 8916933.
18. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. The New England journal of medicine. 1995; 332(14):912-7. Epub 1995/04/06. doi: 10.1056/nejm199504063321403 PMID: 7877648.
19. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. The New England journal of medicine. 1999; 341(11):801-6. Epub 1999/09/09. doi: 10.1056/nejm199909093411104 PMID: 10477778.
20. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. The New England journal of medicine. 1999; 340(1):9-13. Epub 1999/01/08. doi: 10.1056/nejm199901073400102 PMID: 9878639.
21. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 1996; 348(9032):913-6. Epub 1996/10/05. PMID: 8843809.
22. Mahler M, Fritzler MJ. Epitope specificity and significance in systemic autoimmune diseases. Annals of the New York Academy of Sciences. 2010; 1183:267-87. Epub 2010/02/12. doi: 10.1111/j.1749-6632.2009.05127.x PMID: 20146721.
23. Stinton LM, Fritzler MJ. A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders. Autoimmunity reviews. 2007; 7(1):77-84. Epub 2007/10/31. doi: 10.1016/j.autrev.2007.08.003 PMID: 17967730.
24. Goldblatt F, O'Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet. 2013; 382 (9894):797-808. Epub 2013/09/03. doi: 10.1016/s0140-6736(13)61499-3 PMID: 23993190.
25. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of thrombosis and haemostasis: JTH. 2006; 4(2):295-306. Epub 2006/01/20. doi: 10.1111/j.1538-7836.2006.01753.x PMID: 16420554.
26. Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood. 2004; 104 (12):3631-4. Epub 2004/08/07. doi: 10.1182/blood-2004-03-1042 PMID: 15297315.
27. Biino G, Portas L, Murgia F, Vaccargiu S, Parracciani D, Pirastu M, et al. A population-based study of an Italian genetic isolate reveals that mean platelet volume is not a risk factor for thrombosis. Thrombosis research. 2012; 129(4):e8-13. Epub 2011/12/06. doi: 10.1016/j.thromres.2011.11.018 PMID: 22137741.
28. Kujovich JL. Thrombophilia and pregnancy complications. American journal of obstetrics and gynecology. 2004; 191(2):412-24. Epub 2004/09/03. doi: 10.1016/j.ajog.2004.03.001 PMID: 15343215.
29. Ge H, Si Y, Roeder RG. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. The EMBO journal. 1998; 17 (22):6723-9. Epub 1998/11/21. doi: 10.1093/emboj/17.22.6723 PMID: 9822615; PubMed Central PMCID: PMCPmc1171017.
30. Singh DP, Ohguro N, Chylack LT Jr., Shinohara T. Lens epithelium-derived growth factor: increased resistance to thermal and oxidative stresses. Investigative ophthalmology & visual science. 1999; 40 (7):1444-51. Epub 1999/06/08. PMID: 10359326.
31. Chen FF, Lin WH, Lin SC, Kuo JH, Chu HY, Huang WC, et al. Significance of heparin binding to basic residues in homologous to the amino terminus of hepatoma-derived growth factor and related proteins. Glycobiology. 2012; 22(5):649-61. Epub 2012/01/10. doi: 10.1093/glycob/cwr191 PMID: 22223757.
32. Fatma N, Singh DP, Shinohara T, Chylack LT Jr. Heparin's roles in stabilizing, potentiating, and transporting LEDGF into the nucleus. Investigative ophthalmology & visual science. 2000; 41(9):2648-57. Epub 2000/08/11. PMID: 10937578.
33. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. The New England journal of medicine. 2002; 346(10):752-63. Epub 2002/03/08. doi: 10.1056/NEJMra002974 PMID: 11882732.
34. Kelton JG, Warkentin TE. Heparin-induced thrombocytopenia: a historical perspective. Blood. 2008; 112(7):2607-16. Epub 2008/09/24. doi: 10.1182/blood-2008-02-078014 PMID: 18809774.
35. Yoon JH, Jang IK. Heparin-induced thrombocytopenia in cardiovascular patients: pathophysiology, diagnosis, and treatment. Cardiology in review. 2011; 19(3):143-53. Epub 2011/04/06. doi: 10.1097/CRD.0b013e318211f7c0 PMID: 21464642.
36. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis and rheumatism. 2003; 48(10):2741-9. Epub 2003/10/15. doi: 10.1002/art.11223 PMID: 14558078.
37. Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. Jama. 2013; 309(23):2473-9. Epub 2013/06/20. doi: 10.1001/jama.2013.6285 PMID: 23780460.
38. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. The New England journal of medicine. 2003; 349(16):1526-33. Epub 2003/10/17. doi: 10.1056/NEJMoa021933 PMID: 14561795.
39. Ogawa Y, Sugiura K, Watanabe A, Kunimatsu M, Mishima M, Tomita Y, et al. Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain. Journal of autoimmunity. 2004; 23(3):221-31. Epub 2004/10/27. doi: 10.1016/j.jaut.2004.07.003 PMID: 15501393.